- Home
- WIA vs VYGR Comparison
WIA vs VYGR Comparison
Compare WIA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- VYGR
- Stock Information
- Founded
- WIA 2003
- VYGR 2013
- Country
- WIA United States
- VYGR United States
- Employees
- WIA N/A
- VYGR N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- WIA Finance
- VYGR Health Care
- Exchange
- WIA Nasdaq
- VYGR Nasdaq
- Market Cap
- WIA 189.6M
- VYGR 191.9M
- IPO Year
- WIA N/A
- VYGR 2015
- Fundamental
- Price
- WIA $8.27
- VYGR $3.43
- Analyst Decision
- WIA
- VYGR Strong Buy
- Analyst Count
- WIA 0
- VYGR 9
- Target Price
- WIA N/A
- VYGR $14.86
- AVG Volume (30 Days)
- WIA 39.2K
- VYGR 269.4K
- Earning Date
- WIA 01-01-0001
- VYGR 05-06-2025
- Dividend Yield
- WIA 12.29%
- VYGR N/A
- EPS Growth
- WIA N/A
- VYGR N/A
- EPS
- WIA N/A
- VYGR N/A
- Revenue
- WIA N/A
- VYGR $66,958,000.00
- Revenue This Year
- WIA N/A
- VYGR N/A
- Revenue Next Year
- WIA N/A
- VYGR $2.04
- P/E Ratio
- WIA N/A
- VYGR N/A
- Revenue Growth
- WIA N/A
- VYGR N/A
- 52 Week Low
- WIA $7.56
- VYGR $2.75
- 52 Week High
- WIA $8.91
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- WIA 56.31
- VYGR 48.76
- Support Level
- WIA $8.22
- VYGR $3.46
- Resistance Level
- WIA $8.36
- VYGR $3.69
- Average True Range (ATR)
- WIA 0.08
- VYGR 0.18
- MACD
- WIA 0.01
- VYGR 0.02
- Stochastic Oscillator
- WIA 66.67
- VYGR 55.93
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.